US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Abstract, Snapshot, Market Analysis & Market Definition: Global Active Pharmaceutical Ingredient MarketThe global Active Pharmaceutical Ingredient market size is projected to reach US$ 267.69 billion by 2026, from US$ 180.39 billion in 2020, at a CAGR of 6.8% during 2021-2026. Advancements in API manufacturing and growth of biopharmaceutical sector are expected to be the key factors driving the market. In addition, increasing geriatric population across the globe is also anticipated to contribute to the market growth. Increasing prevalence of infectious diseases and Hospital-Acquired Infections (HAIs) are expected to fuel the market growth during the forecast period. Furthermore, rising number of cases of cardiovascular, neurological, and genetic disorders is expected to augment the growth further. Cardiovascular Diseases (CVDs) are the most prevalent cause of death across the globe. According to the Canadian Patient Safety Institute (CPSI), annually around 8,000 patients in Canada die due to HAIs and approximately 220,000 patients are infected with such disease.Targeted therapy is gaining popularity as it only aims at cancerous cells. The characteristics, such as minimum effect of the drug on noncancerous cells, and effectiveness possessed by these anti-cancerous drugs are the factors contributing to the market growth. API production requires huge capital amount as the process needs extremely systematic protocols. Thus, pharmaceutical companies can actually benefit from outsourcing the API production, as it eliminates the need for labor force and installing expensive manufacturing units. Strategic outsourcing allows companies to focus on their core competencies, ultimately resulting in an increased productivity. These factors are also projected to spur the market growth.
Market Segmentation, Outlook & Viewpoint: Global Active Pharmaceutical Ingredient Market
Type of Synthesis Market Segmentation & Outlook (Revenue, USD Billion, 2014 - 2026)
- Monoclonal antibodies
- Recombinant proteins
Type of Manufacturer Market Segmentation & Outlook (Revenue, USD Billion, 2014 - 2026)
- Captive APIs
- Merchant APIs
Type Market Segmentation & Outlook (Revenue, USD Billion, 2014 - 2026)
- Generic APIs
- Innovative APIs
Application Market Segmentation & Outlook (Revenue, USD Billion, 2014 - 2026)
CNS & Neurology
Key Players, Recent Developments & Regional Insights: Global Active Pharmaceutical Ingredient MarketBased on application, the market is segmented into cardiology, oncology, CNS & neurology, and endocrinology. Cardiology segment led the overall market in 2018 owing to the increasing prevalence of target diseases worldwide. According to the WHO, CVDs, particularly heart attack and stroke, account for around 17.5 million deaths across the globe. Cardiovascular disease is one of the global, critical public health burdens, responsible for extensive R&D for APIs in the field. Oncology is expected to be the fastest-growing segment and is driven by factors, such as increasing lifestyle changes and rising prevalence of cancer. Moreover, extensive R&D for the development of drugs specific to novel biomarkers will spur the market growth. There are numerous APIs in the market for cancer treatment, some of which include Rituximab, Bevacizumab, and Trastuzumab by Roche and Imatinib by Novartis.
Regional InsightsNorth America led the market in 2018 owing to technological advancements coupled with high economic development in the region. Increasing prevalence of cancer and other lifestyle-induced diseases is encouraging the R&D activities, thereby boosting the market growth. Asia Pacific is estimated to be the fastest-growing region over the forecast period. Availability of cheap labor and lenient regulatory framework are attracting foreign companies to set up manufacturing facilities in Asia Pacific.
Active Pharmaceutical Ingredient (API) Market Share InsightsSome of the key companies in the market are Teva Pharmaceutical Industries Ltd.; AbbVie, Inc.; Boehringer Ingelheim International GmbH; Cipla, Inc.; Merck & Co., Inc.; Bristol-Myers Squibb Company; Albemarle Corporation; Mylan N.V.; Aurobindo Pharma; Sun Pharmaceutical Industries Ltd.; and Dr. Reddys Laboratories Ltd. Most of these companies follow strategies, such as acquisitions and collaborations, to maintain their market position. For instance, in November 2016, Arrow Generiques SAS, a subsidiary of Aurobindo Pharma Ltd., acquired whole rights of Calcium Vitamin D3 and Calcium products from Teva Pharmaceutical Industries Ltd. in France.
Key Insights Covered: Global Active Pharmaceutical Ingredient Market1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Active Pharmaceutical Ingredient industry. 2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Active Pharmaceutical Ingredient industry. 3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Active Pharmaceutical Ingredient industry. 4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Active Pharmaceutical Ingredient industry. 5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Active Pharmaceutical Ingredient industry.
Research Methodology: Global Active Pharmaceutical Ingredient Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other
Table of Contents Chapter 1 Methodology And Scope 1.1 Market Segmentation 1.2 Market Definition 1.3 Information Procurement 1.3.1 Purchased Database 1.3.2. HCC’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.4 Information Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Data Visualization 1.6 Validation & Publishing 1.7 Geographic Scope & Assumptions 1.8 Region-Wise Market Calculation 1.8.1 Region-Wise Market: Base Estimates 1.9 Market CAGR Calculation 1.9.1 Region Based Segment Share CalculationChapt | read more...